Madina Kurmanalina

Dr. Madina Kurmanalina

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2024 in West Kazakhstan Medical Journal
Verified
Journal Article
Open access
PDF file
MKMadina Kurmanalina
Madina Kurmanalina
MUMarina M. Urazalina
Marina M. Urazalina
GAGulshara A. Abasheva
Gulshara A. Abasheva
AAAruzhan M. Aitmukhanbetova
Aruzhan M. Aitmukhanbetova
Mesenchymal stem cells (MSCs) have garnered significant attention in regenerative dentistry due to their remarkable ability to differentiate into various cell types and their immunomodulatory properties. This review provides a comprehensive overview of recent advancements in MSC research relevant to dentistry, focusing on their potential applications in periodontal tissue regeneration, dental pulp regeneration, and maxillofacial bone repair. Periodontal diseases, which affect the tissues surrounding and supporting the teeth, are a significant challenge in dentistry. Current treatments often involve surgical intervention and tissue grafting. MSCs have shown promise as a potential alternative for periodontal tissue regeneration, as they can differentiate into periodontal ligament cells, cementoblasts, and osteoblasts. Several preclinical and clinical studies have demonstrated the efficacy of MSC-based therapies in periodontal regeneration. Dental pulp regeneration is another area where MSCs hold promise. Damaged or infected dental pulp can lead to pulpitis or pulp necrosis, necessitating root canal treatment. MSCs have been studied for their ability to regenerate dental pulp tissue and promote pulp healing. They can differentiate into odontoblast-like cells and regenerate dentin-like tissue, making them a potential treatment option for dental pulp regeneration. In maxillofacial bone repair, MSCs have been investigated for their osteogenic differentiation potential and ability to stimulate bone regeneration. Studies have shown promising results, suggesting that MSC-based therapies could be a viable treatment option for maxillofacial bone defects. The mechanisms underlying MSC-based therapies in dentistry are not fully understood but are thought to involve a combination of paracrine effects, immunomodulation, and differentiation into specific cell types. Future research should focus on addressing these challenges and exploring novel approaches for enhancing the regenerative potential of MSCs in dentistry.

12 January 2026 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MEMohammad Saleh Ekrampoor
Mohammad Saleh Ekrampoor
HDHossein Daneste
Hossein Daneste
MKMehdi Kian
Mehdi Kian
FNfariborz nowzari
fariborz nowzari
SAShekofeh Abbaspour
Shekofeh Abbaspour
Amin TamadonAmin Tamadon
Amin Tamadon

12 January 2026 in Odontology
Verified
Journal Article
Closed access
PDF file
NJNazanin Jafari
Nazanin Jafari
Amin TamadonAmin Tamadon
Amin Tamadon
MKMadina Kurmanalina
Madina Kurmanalina
NMNadiar Maratovich Mussin
Nadiar Maratovich Mussin
NTNader Tanideh
Nader Tanideh
RSRamazon Safarzoda Sharoffidin
Ramazon Safarzoda Sharoffidin

1 January 2025 in Stem Cells International
Verified
Journal Article
Open access
NMNadiar Maratovich Mussin
Nadiar Maratovich Mussin
KZKulyash Zhilisbayeva
Kulyash Zhilisbayeva
ABAkmaral Baspakova
Akmaral Baspakova
MKMadina Kurmanalina
Madina Kurmanalina
Amin TamadonAmin Tamadon
Amin Tamadon
Mesenchymal stem cell (MSC)‐derived extracellular vesicles (EVs), including exosomes, have garnered significant attention for their therapeutic potential in regenerative medicine and inflammatory disease management. This bibliometric analysis maps the global research landscape of MSC‐derived EV studies from 2014 to 2025, utilizing data from Web of Science (WoS), Scopus, and PubMed. A total of 99 research articles were analyzed after screening 335 initial records, focusing on publication trends, citation metrics, collaboration networks, and thematic evolution. The field exhibited a 27.11% annual publication growth rate, with 841 authors contributing to 70 journals, reflecting its interdisciplinary and collaborative nature. Key findings include a surge in publications from 2018 onward, driven by clinical trials targeting conditions such as COVID‐19, osteoarthritis, and spinal cord injury. The United States and China led international collaborations, with 22.68% of publications involving cross‐border co‐authorships. Keyword analysis revealed a shift from foundational terms like “exosomes” to clinical applications like “immunomodulation” and “osteoarthritis.” Despite the field’s promise, limitations such as partial 2025 data and exclusion of non‐English studies suggest areas for broader inclusion. This study underscores the rapid growth and clinical potential of MSC‐derived EV research, providing insights for researchers and policymakers to advance therapeutic development.

7 January 2026 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
NMNadiar Maratovich Mussin
Nadiar Maratovich Mussin
KZKulyash Zhilisbayeva
Kulyash Zhilisbayeva
ABAkmaral Baspakova
Akmaral Baspakova
BKBibigul K. Karimsakova
Bibigul K. Karimsakova
GTGulzhan A. Tulegenova
Gulzhan A. Tulegenova
Amin TamadonAmin Tamadon
Amin Tamadon

4 May 2025 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
MKMadina Kurmanalina
Madina Kurmanalina
MIMoldir B. Ismagulova
Moldir B. Ismagulova
Amin TamadonAmin Tamadon
Amin Tamadon
This study presents a comprehensive bibliometric analysis of artificial intelligence (AI) applications in the diagnosis of oral diseases, aiming to explore publication trends, identify key contributors, and highlight emerging research directions. Utilizing data from the Web of Science and Scopus databases, we analyzed 90 relevant publications after refining an initial pool of 179 articles. The results reveal a significant increase in research output since 2016, with a peak in 2023, followed by a decline in 2024. Early research, dating back to 1996, focused on decision-support systems, while recent advancements emphasize deep learning, machine learning, and radiographic imaging for improved diagnostic accuracy. Keyword analysis identified "artificial intelligence," "deep learning," and "diagnosis" as central themes, reflecting the field's focus on technological innovation in oral healthcare. Geographically, China, the United States, and India emerged as leading contributors, with strong international collaborations observed between these countries and regions such as Europe and the Middle East. Despite the growing interest, challenges such as funding constraints and regulatory hurdles may have contributed to the recent decline in publications. This study underscores the transformative potential of AI in oral disease diagnosis and provides a roadmap for future research, emphasizing the need for global collaboration, inclusivity, and continuous monitoring of emerging trends to advance precision dentistry.